American Century Companies, Inc. and affiliated entities filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership positions in Nu Skin Enterprises, Inc. Class A Common Stock as of September 30, 2026.
Key Highlights
- Event date: The filing is triggered by ownership as of September 30, 2026.
- American Century Companies and ACIM: Each reports beneficial ownership of 2,691,940 shares of Nu Skin Enterprises Class A Common Stock, representing 5.5% of the class.
- American Century ETF Trust: Reports beneficial ownership of 2,650,649 shares, representing 5.4% of the class.
- Voting and dispositive power: All reported shares for each entity are held with sole voting and sole dispositive power; shared voting and shared dispositive power are each reported as 0.
- Corporate structure: According to the filing, American Century Investment Management, Inc. (ACIM) is a wholly-owned subsidiary of American Century Companies, Inc. (ACC), which is controlled by the Stowers Institute for Medical Research.
- Ordinary course certification: The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
American Century Entities Report Positions in Nu Skin Class A Shares
Four related entities filed a joint Schedule 13G disclosing their beneficial ownership in Nu Skin Enterprises, Inc. (NYSE:NUS) Class A Common Stock. The reporting persons are American Century ETF Trust, American Century Investment Management, Inc. (ACIM), American Century Companies, Inc. (ACC), and Stowers Institute for Medical Research, all organized in Delaware and sharing a principal business address at 4500 Main Street, 9th Floor, Kansas City, Missouri 64111, according to the filing.
The filing reports that ACIM and ACC each beneficially own 2,691,940 shares, equating to 5.5% of the class, while American Century ETF Trust separately reports 2,650,649 shares, or 5.4% of the class. In each case, the filing attributes all shares to sole voting power and sole dispositive power, with no shared voting or dispositive authority reported. The filing notes that "various persons, including the investment companies and separate institutional investor accounts that ACIM serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities," and that no single client advised by ACIM owns more than 5% of the class.
The filing identifies ACIM as a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. ACC itself is described as controlled by the Stowers Institute for Medical Research, which is listed as a holding company (type HC) in the filing. The Schedule 13G was signed on November 16, 2026, by John Pak, Senior Vice President, on behalf of the reporting entities.
What Was Disclosed
Four affiliated American Century entities filed a Schedule 13G reporting beneficial ownership of Nu Skin Enterprises Class A Common Stock as of September 30, 2026, with the largest positions at 2,691,940 shares (5.5% of the class) held by ACIM and ACC.




Please wait processing your request...